Orion Oyj, known by the ticker symbol ORINY, is a Finnish pharmaceutical firm in the Healthcare Sector. This is my first report on ORINY for my Viital stock portfolio, However, I last reported on this company on   August 10, 2021, when I reviewed it for my Vista portfolio.

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. 

Image Source: Pixabay

The company primarily focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. 

Orion mainly serves Finland but also has a presence in other European countries and North America.

Orion Oyj has a partnership with Propeller Health to connect the Easyhaler(R) line of inhalers for asthma and COPD to Propeller's digital medicine platform, and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop new bispecific antibody cancer therapeutics. 

Orion Oyj is headquartered in Espoo, Finland.

Three key data points gauge dividend equities or funds like Orion Oyj (ORINY):

(1) Price

(2) Dividends

(3) Returns

Those three basic keys best tell whether any company has made, is making, and will make money. 

ORINY Price

Orion Oyj's price per share was $21.30 as of yesterday's market close. One year ago its price was $25.05 So ORINY's share price fell about 15% in the past year.

If ORINY's stock trades in the range of $20.00 to $26.00 this next year, its recent $21.30 price will likely stay level or drop $1.30 by October 12, 2022. My estimate is based on the narrow range trajectory traced by six years of price data because no brokerage analysts track the stock.

ORINY Dividends

Orion Oyj's most recent annual dividend of  $0.89 was paid out on April 22 to shareholders. That annual payout of yields 4.18% based on yesterday's $21.30 closing price. Orion Oyj has paid regular annual dividends since April 2016. That's 6 years.

ORINY Returns

Adding the $0.89 annual Healthcare Services Group forward-looking dividend to my $null price upside estimate shows an $0.89 potential gross gain, per share, to be reduced by any costs to trade ORINY  shares.  

At yesterday's $21.30 price per share, a little over $1000 would buy 47 shares.

A $10 broker fee (if charged) would be paid half at purchase and half at sale and might cost us about $0.21 per share.

Subtract that maybe $0.22 brokerage cost from my estimated $0.89 gross gain per share results in a net gain of $0.67 X 47 shares = $31.67 for a 3.17% net gain on a $1,001.10 investment.

So it is that Orion Oyj (ORINY) shows a possible 3.17% net gain including a 4.18% forward estimated dividend yield. 

Over the next year at this time, a $1000 investment in Orion Oyj (ORINY) could generate $41.80 in cash dividends alone. And a single share bought at yesterday's closing price was $21.30! Thus, ORINY's share price is $20.50 less than the dividend income from $1K invested. So, according to my dogcatcher ideal, now is the time to pick up ORINY shares. The dividend from $1k invested is $20.50 greater than the single share price. Consider yourself alerted. It's a sign!

All of the estimates above are speculation based on the past history of Orion Oyj (ORINY). Only time and money invested in this stock will determine its market value.